Negative findings with megavitamins in schizophrenic patients: preliminary report. 1977

T A Ban, and H E Lehmann, and M Deutsch

UI MeSH Term Description Entries
D009974 Orthomolecular Therapy The use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders. Megavitamin Therapy,Therapy, Megavitamin,Therapy, Orthomolecular,Megavitamin Therapies,Orthomolecular Therapies,Therapies, Megavitamin,Therapies, Orthomolecular
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T A Ban, and H E Lehmann, and M Deutsch
October 1949, The Psychiatric quarterly,
T A Ban, and H E Lehmann, and M Deutsch
January 1967, The Journal of clinical pharmacology and the journal of new drugs,
T A Ban, and H E Lehmann, and M Deutsch
July 1990, Pharmacopsychiatry,
T A Ban, and H E Lehmann, and M Deutsch
November 1961, Canadian Medical Association journal,
T A Ban, and H E Lehmann, and M Deutsch
November 1981, Biological psychiatry,
T A Ban, and H E Lehmann, and M Deutsch
July 1985, Indian journal of psychiatry,
T A Ban, and H E Lehmann, and M Deutsch
January 1993, European archives of psychiatry and clinical neuroscience,
T A Ban, and H E Lehmann, and M Deutsch
January 1984, Neuropsychobiology,
T A Ban, and H E Lehmann, and M Deutsch
September 1994, Psychiatry research,
T A Ban, and H E Lehmann, and M Deutsch
November 1957, Diseases of the nervous system,
Copied contents to your clipboard!